Opasich C, Pacini F, Ambrosino N, Riccardi P G, Febo O, Ferrari R, Cobelli F, Tavazzi L
S. Maugeri Foundation, Institute of Care and Scientific Research, Italy.
Eur Heart J. 1996 Dec;17(12):1860-6. doi: 10.1093/oxfordjournals.eurheartj.a014804.
Changes in peripheral thyroid hormone concentration and metabolism can occur in euthyroid patients suffering from severe non-thyroidal illnesses. Recently, sick euthyroid syndrome has been reported in patients suffering from advanced heart failure.
This study was to evaluate prospectively the presence and pathophysiological implications of sick euthyroid syndrome in moderate-to-severe chronic heart failure patients.
The study population were 199 chronic heart failure patients admitted over a 2-year period to our heart failure unit for assessment of cardiac transplantation. They were closely followed up with clinical and instrumental examinations (including clinical, hormonal, nutritional and cardiac function evaluations). Sick euthyroid syndrome was defined as a serum total triiodothyronine value of less than the lowest normal limit (< 1.23 nmol.l-1) in the presence of a normal serum thyroid stimulating hormone concentration.
Sick euthyroid syndrome was found in 36/199 patients (18%). According to the New York Heart Association (NYHA) classification of severity of heart failure, sick euthyroid syndrome patients appear in higher NYHA classes (31% of classes III and IV, vs 7% of class I and II). Such patients also weigh less and are more frequently malnourished. Alterations in cardiac index, ventricular filling pressures, functional impairment, and the liver function parameters, were more significant in sick euthyroid syndrome than in non-sick euthyroid syndrome patients. Serum norepinephrine and atrial natriuretic factor were significantly higher, and insulin significantly lower in the sick euthyroid syndrome group. During follow-up, deaths were significantly more frequent in sick euthyroid syndrome patients (13/27, 48%) than in non-sick euthyroid syndrome (30/141, 21%; P < 0.005). In six sick euthyroid syndrome patients who underwent heart transplantation, mean total triiodothyronine values increased from 0.9 +/- 0.1 before to 1.96 +/- 0.3 nmol.l(-1)post-transplantation (P < 0.05).
In a large and representative population of patients with moderate-to-severe heart failure, sick euthyroid syndrome shows a prevalence of 18%. Its occurrence was related to the degree of functional cardiac impairment, but was not an independent negative prognostic factor. Preliminary results indicate that heart transplantation is associated with reversibility of sick euthyroid syndrome.
患有严重非甲状腺疾病的甲状腺功能正常的患者,其外周甲状腺激素浓度和代谢会发生变化。最近,在晚期心力衰竭患者中报道了病态甲状腺综合征。
本研究旨在前瞻性评估中度至重度慢性心力衰竭患者中病态甲状腺综合征的存在情况及其病理生理意义。
研究对象为在两年期间入住我们心力衰竭病房接受心脏移植评估的199例慢性心力衰竭患者。对他们进行密切的临床和仪器检查随访(包括临床、激素、营养和心脏功能评估)。病态甲状腺综合征定义为血清总三碘甲状腺原氨酸值低于正常下限(<1.23nmol·l-1),同时血清促甲状腺激素浓度正常。
199例患者中有36例(18%)发现病态甲状腺综合征。根据纽约心脏协会(NYHA)心力衰竭严重程度分级,病态甲状腺综合征患者更多出现在NYHA较高分级中(III级和IV级中的31%,而I级和II级中的7%)。这类患者体重也更轻,营养不良更为常见。与非病态甲状腺综合征患者相比,病态甲状腺综合征患者的心脏指数、心室充盈压、功能损害和肝功能参数的改变更为显著。病态甲状腺综合征组血清去甲肾上腺素和心房利钠因子显著更高,而胰岛素显著更低。随访期间,病态甲状腺综合征患者的死亡频率显著高于非病态甲状腺综合征患者(27例中有13例,48%,而141例中有30例,21%;P<0.005)。在6例接受心脏移植的病态甲状腺综合征患者中,平均总三碘甲状腺原氨酸值从移植前的0.9±0.1增加到移植后的1.96±0.3nmol·l-1(P<0.05)。
在一大组具有代表性的中度至重度心力衰竭患者中,病态甲状腺综合征的患病率为18%。其发生与心脏功能损害程度有关,但不是独立的不良预后因素。初步结果表明,心脏移植与病态甲状腺综合征的可逆性相关。